Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO/ONOO- cycle

Medical Hypotheses

Volumn 69, Issue 4, 2007, Pages 821-825

  Pall, Martin L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; TETRAHYDROBIOPTERIN;

ARTICLE; CHRONIC FATIGUE SYNDROME; ENZYME ACTIVITY; FIBROMYALGIA; HUMAN; MULTIPLE CHEMICAL SENSITIVITY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; STRESS;

DRUG HYPERSENSITIVITY; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; HUMANS; MODELS, BIOLOGICAL; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STRESS DISORDERS, POST-TRAUMATIC; UNCOUPLING AGENTS;

EID: 34547852271     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.070     Document Type: Article

References (26)

1. Pall M.L. Explaining "unexplained illnesses": disease paradigm for chronic fatigue syndrome, multiple chemical sensitivity, fibromyalgia, post-traumatic stress disorder, Gulf war syndrome and others (2007), Haworth Medical Press, New York
2. Pall M.L. The NO/ONOO- cycle as the cause of fibromyalgia and related illnesses: etiology, explanation and effective therapy. In: Pederson J.A. (Ed). New research in fibromyalgia (2006), Nova Science, Commack, NY 39-61
3. Pall M.L. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypoth 54 (2000) 115-125
4. Pall M.L. NMDA sensitization and stimulation by peroxynitrite, nitric oxide and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity. FASEB J 16 (2002) 1407-1417
5. Pall M.L., and Anderson J.H. The vanilloid receptor as the putative target of diverse chemicals in multiple chemical sensitivity. Arch Environ Health 59 (2004) 363-375
6. Pall ML. Multiple chemical sensitivity: towards the end of controversy. Townsend Lett Doctors Patients, August/September; 2005. p. 52-6.
7. Vasquez-Vivar J., Hogg N., Martasek P., et al. Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 274 (1999) 26736-26742
8. Andrew P.J., and Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43 (1999) 521-531
9. Gorren A.C., Schrammel A., Riethmuller C., et al. Nitric oxide-induced autoinhibition of neuronal nitric oxide synthase in the presence of the autoxidation-resistant pteridine 5-methyltetrahydrobiopterin. Biochem J 347 Pt2 (2000) 475-484
10. Huisman A., Vos I., van Faasen E.E., et al. Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J 16 (2002) 1135-1137
11. Cardounel A.J., Xia Y., and Zweier J.L. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin. J Biol Chem 280 (2005) 7540-7549
12. Kuzkaya N., Weissmann N., Harrison D.G., and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278 (2003) 22546-22554
13. Alp N.J., and Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arteriosler Thromb Vasc Biol 24 (2004) 413-420
14. Kawashima S. Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis. J Pharmacol Sci 96 (2004) 411-419
15. Delgado-Estaban M., Almeida A., and Medina J.M. Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. J Neurochem 82 (2002) 1148-1159
16. Milstien S., and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263 (1999) 681-684
17. Kohnen S.L., Mouithys-Mickalad A.A., Deby-Dupont G.P., et al. Oxidation of tetrahydrobiopterin by peroxynitrite or oxoferryl species occurs by a radical pathway. Free Radic Res 35 (2001) 709-721
18. Kuhn D.M., and Geddes T.J. Tetrahydrobiopterin prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide. Mol Pharmacol 64 (2003) 946-953
19. Botez M.I., Botez T., Leveille J., Beilmann T., and Cadotte M. Neuropsychological correlates of folic acid deficiency: facts and hypotheses. In: Botez M.I., and Reynolds E.H. (Eds). Folic acid in neurology, psychiatry and internal medicine (1979), Raven Press, New York 425-461
20. Lundell K., Qazi S., Eddy L., and Uckun F.M. Clinical activity of folinic acid in patients with chronic fatigue syndrome. Arzneimittelforschung 56 (2006) 399-404
21. Danfors T., von Knorring A.-L., Hartvig P., et al. Tetrahydrobiopterin in the treatment of children with autistic disorder: A double-blind placebo-controlled crossover study. J Clin Psychopharmacol 25 (2005) 485-489
22. Naruse H., Hayashi T., Takesada M., et al. Therapeutic effect of tetrahydrobiopterin in infantile autism. Proc Jpn Acad 63B (1987) 231-233
23. Fernell E., Watanabe Y., Adolfsson I., et al. Possible effects of tetrahydrobiopterin treatment of in six children with autism - clinical and positron emission tomography data. Dev Med Child Neurol 39 (1997) 313-318
24. Shang T., Kotamraju S., Zhao H., Kalivendi S.V., Hillard C.J., and Kalyanaraman B. Sepiapterin attenuates 1-methyl-4-phenylpyridinium-induced apoptosis in neuroblastoma cells transfected with neuronal NOS: role of tetrahydrobiopterin, nitric oxide and proteasome activation. Free Radic Biol Med 39 (2005) 1059-1074
25. Shang T., Kotamraju S., Kalivendi S.V., Hillard C.J., and Kalyanaraman B. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric oxide-derived superoxide. J Biol Chem 279 (2004) 19099-19112
26. Pall M.L. Cobalamin used in chronic fatigue syndrome therapy is a nitric oxide scavenger. J Chronic Fatigue Synd 8 (2001) 39-44